Coronavirus infectious disease-2019 (COVID-19) : a case report, the first patient in Thailand and outside China
Main Article Content
Abstract
Coronavirus infectious disease-2019 (COVID-19): a case report, the first patient in Thailand and outside China.Coronavirus infectious disease-2019 (COVID-19) was identified in China on December 2019 and the fastest emerging infectious disease, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, has become a worldwide pandemic and serious public health concern. The symptoms of COVID-19 are vary widely from asymptomatic disease to pneumonia and life-threatening complications, including acute respiratory distress syndrome, multisystem organ failure and death. The current management mainly are supportive care. Bamrasnaradura Infectious diseases Institute (BIDI) is the first hospital in Thailand that had prepared to isolate and quarantine all of the COVID-19 patients.
This is a case report of the first patient who was diagnosed with COVID-19 in Thailand and outside China. She is Chinese tourist, was detected high-grade fever at Suvarnabhumi airport and transferred to admit at BIDI airborne infection isolation room (AIIR). Her symptom was flu- like illness, after we followed her chest radiography revealed abnormal reticulopatchy infiltration at peripheral right upper lung region but she had no pneumonia symptom. Her clinically improved without specific drug and her oropharyngeal swab had return to be undetectable and discharged.
Article Details
References
World Health Organization. Pneumonia of unknown cause: China [Internet]. 2020. [Cited 2020 Apr 15]. Available from: https://www.who.int/csr/don/05-january-2020-pneumonia-of-unkown-cause-china/en/
World Health Organization. Novel coronavirus: China [Internet]. 2020. [Cited 2020 Apr 15]. Available from: https://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en/
Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. N Engl J Med 2020 Mar 26; 382(13): 1199-207. doi: 10.1056/NEJMoa2001316.
Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C, et al. Transmission of2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med 2020 Mar 5; 382(10): 970-71. doi: 10.1056/NEJMc2001468.
Pongpirul WA, Pongpirul K, Ratnarathon AC, Prasithsirikul W. Journey of a Thai Taxi Driver and Novel Coronavirus. N Engl J Med 2020 Mar 12; 382(11): 1067-8. doi: 10.1056/NEJMc2001621. PMID: 32050060.
Wei-jie G, Zheng-yi N, Yu H, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Eng J Med 2020 Apr 30; 382: 1708-20. doi: 10.1056/NEJMoa2002032.
Kim D, Quinn J, Pinsky B, Shah NH, Brown L. Rates of co-infection between SARS-CoV-2 and other respiratory pathogens. JAMA 2020 Apr 15. doi: 10.1001/jama.2020.6266.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020 Feb 15; 395(10223): 497-506. doi:10.1016/S0140-6736(20)30183-5. PMID: 31986264.
Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G,et al. A trial of lopinavir-ritonavir in adults hospitalized with sever covid-19. N Engl J Med 2020 Mar 18. doi: 10.1056/NEJMoa2001282.
Pongpirul WA, Mott JA, Woodring JV, UyekiTM, MacArthur JR, Vachiraphan A, et al. Clinical characteristics of patients hospitalized with coronavirus disease, Thailand. Emerg Infect Dis 2020 Apr 8; 26(7). doi: 10.3201/eid2607.200598. PMID: 32267826.
Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, et al. First case of 2019 novel coronavirus in the United States. N Engl J Med 2020 Mar 5; 382(10): 929-36. doi:10.1056/NEJMoa2001191.